Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Top Cited Papers
Open Access
- 1 April 2006
- journal article
- research article
- Published by Elsevier in Molecular Cell
- Vol. 22 (2) , 159-168
- https://doi.org/10.1016/j.molcel.2006.03.029
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancerNature Medicine, 2005
- An expanding role for mTOR in cancerPublished by Elsevier ,2005
- Structure of S6 Kinase 1 Determines whether Raptor-mTOR or Rictor-mTOR Phosphorylates Its Hydrophobic Motif SiteJournal of Biological Chemistry, 2005
- Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR ComplexScience, 2005
- Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitiveNature Cell Biology, 2004
- PTENGene Targeting Reveals a Radiation-Induced Size Checkpoint in Human Cancer CellsCancer Research, 2004
- Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivityNature, 2004
- The impact of Sirolimus Eluting stents in interventional cardiologyInternational Journal of Cardiology, 2004
- Mammalian target of rapamycin inhibition as therapy for hematologic malignanciesCancer, 2004
- mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth MachineryCell, 2002